Institutional Ownership Eledon Pharmaceuticals, Inc. (ELDN)
This table provides information about the institutional ownership of Eledon Pharmaceuticals, Inc. (ELDN). We have compiled data on the 94 institutions that hold shares in the stock, with a total of 38.1 Million shares, which have been reported (via 13F filing form) to have a value of $104 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
213,101
shares
|
$566,848
0.0% of portfolio
|
Q1 2025
Added 13.96%
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
188,485
shares
|
$501,370
0.0% of portfolio
|
Q1 2025
New holding
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Aug 12, 2025 Q2 2025 |
177,249
shares
|
$471,482
0.0% of portfolio
|
Q2 2025
Added 491.09%
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
175,891
shares
|
$467,870
0.0% of portfolio
|
Q1 2025
Added 44.01%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
155,080
shares
|
$412,512
0.0% of portfolio
|
Q2 2024
Added 477.99%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Aug 12, 2025 Q2 2025 |
136,456
shares
|
$362,972
0.0% of portfolio
|
Q2 2025
Added 17.46%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
130,673
shares
|
$347,590
0.0% of portfolio
|
Q1 2025
Added 2.99%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
122,773
shares
|
$326,576
0.0% of portfolio
|
Q1 2025
Reduced 16.58%
|
|
Exome Asset Management LLC
New York, NY |
May 15, 2025 Q1 2025 |
114,145
shares
|
$303,625
0.34% of portfolio
|
Q1 2025
Reduced 55.48%
|
|
Hrt Financial LP
New York, NY |
May 15, 2025 Q1 2025 |
113,275
shares
|
$301,311
0.0% of portfolio
|
Q1 2025
New holding
|
|
Allostery Investments LP
Stamford, CT |
May 15, 2025 Q1 2025 |
100,000
shares
|
$266,000
0.49% of portfolio
|
Q4 2024
New holding
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
93,997
shares
|
$250,032
0.0% of portfolio
|
Q1 2025
Reduced 50.49%
|
|
Nuveen, LLC
Charlotte, NC |
Aug 12, 2025 Q2 2025 |
76,292
shares
|
$202,936
0.0% of portfolio
|
Q2 2025
New holding
|
|
Barclays PLC
London, X0 |
May 15, 2025 Q1 2025 |
70,000
shares
|
$186,200
0.0% of portfolio
|
Q4 2024
New holding
|
|
Jain Global LLC
New York, NY |
May 15, 2025 Q1 2025 |
67,212
shares
|
$178,783
0.0% of portfolio
|
Q1 2025
New holding
|
|
Diadema Partners LP
Morristown, NJ |
May 15, 2025 Q1 2025 |
64,613
shares
|
$171,870
0.06% of portfolio
|
Q1 2025
Reduced 14.75%
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 15, 2025 Q1 2025 |
61,520
shares
|
$163,643
0.0% of portfolio
|
Q1 2025
Added 88.58%
|
|
Rhumbline Advisers
Boston, MA |
Aug 12, 2025 Q2 2025 |
56,050
shares
|
$149,093
0.0% of portfolio
|
Q2 2025
New holding
|
|
Ingalls & Snyder LLC
New York, NY |
Jul 31, 2025 Q2 2025 |
51,849
shares
|
$137,918
0.01% of portfolio
|
Q3 2023
Added 1.97%
|
|
Prelude Capital Management, LLC
New York, NY |
May 15, 2025 Q1 2025 |
39,371
shares
|
$104,726
0.01% of portfolio
|
Q1 2025
Reduced 47.21%
|
|
Lmr Partners LLP
London, X0 |
May 15, 2025 Q1 2025 |
37,783
shares
|
$100,502
0.0% of portfolio
|
Q1 2025
New holding
|
|
New York State Common Retirement Fund
|
Aug 13, 2025 Q2 2025 |
36,400
shares
|
$96,824
0.0% of portfolio
|
Q2 2025
New holding
|
|
American Century Companies Inc
Kansas City, MO |
Aug 12, 2025 Q2 2025 |
35,592
shares
|
$94,674
0.0% of portfolio
|
Q2 2025
New holding
|
|
Bridgeway Capital Management, LLC
Houston, TX |
May 15, 2025 Q1 2025 |
33,400
shares
|
$88,844
0.0% of portfolio
|
Q2 2024
New holding
|
|
Marco Investment Management LLC
|
Aug 06, 2025 Q2 2025 |
30,344
shares
|
$80,715
0.01% of portfolio
|
Q2 2024
Added 22.31%
|